Glucos Viaflo

Glucos Viaflo is an intravenous solution whose active ingredient is glucose. The product is supplied in a sterile liquid form, marketed in the European Union. It provides a carbohydrate substrate for energy metabolism when administered intravenously, and is used in clinical settings where rapid glucose delivery is required. It is typically stored at controlled temperature and prepared under aseptic conditions to maintain stability for safe administration.

Glucos Viaflo is indicated for several clinical situations that require immediate glucose supplementation or fluid replacement, such as managing low blood sugar, supporting parenteral nutrition, and correcting fluid deficits.

- Treatment of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens to supply carbohydrate calories. - Fluid replacement in patients with dehydration combined with caloric needs. - Support during surgery or intensive care when rapid glucose infusion is required. - Adjunct in electrolyte solutions to maintain osmolar balance.

When administered intravenously, Glucos Viaflo may be associated with a range of observed effects, most of which are related to its glucose content and infusion rate.

Common: - Transient increase in blood glucose levels. - Mild hyperosmolarity causing temporary thirst. - Local irritation at the infusion site. - Nausea or mild abdominal discomfort. - Headache related to rapid glucose shifts.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Electrolyte imbalance, particularly low potassium. - Fluid overload with pulmonary edema risk. - Allergic reaction such as urticaria or anaphylaxis. - Metabolic acidosis in prolonged high‑dose infusions.

Clinicians should observe several precautions when prescribing Glucos Viaflo to ensure patient safety and optimal therapeutic outcome.

- Verify blood glucose levels before and during infusion. - Adjust dose in patients with renal or hepatic impairment. - Monitor electrolytes, especially potassium and sodium, during therapy. - Use caution in patients with heart failure or fluid overload risk. - Avoid rapid infusion rates that exceed recommended guidelines. - Ensure aseptic technique to prevent catheter‑related infections.

Glucos Viaflo can interact with other medications or solutions; awareness of these interactions helps prevent adverse events.

Avoid: - Co‑administration with high‑dose insulin without glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that may exacerbate hyperosmolarity. - Use with catecholamine vasopressors that can increase glucose production.

Use with caution: - Concurrent use of diuretics that may alter electrolyte balance. - Administration alongside beta‑blockers that mask hypoglycemia symptoms. - Overlap with total parenteral nutrition formulas to avoid excess carbohydrate load.